| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.001 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |